Navigation Links
TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
Date:5/1/2009

LA JOLLA, Calif., May 1 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today reported financial results for the first quarter ended March 31, 2009. For the three-month period, the company posted a net loss of $2.1 million. Cash and cash equivalents totaled $6.3 million at March 31, 2009.

On April 15, 2009, the Company hired Merriman Curhan Ford as its financial advisor to assist in the evaluation of strategic options, including the possible sale of the Company or its assets.

Financial Results

Revenue for the three month period ended March 31, 2009 was $0 compared to revenue of $2.0 million for the same period in 2008. Operating expenses for the quarter ended March 31, 2009 were $2.1 million, with $0.9 million attributable to research and development. This compares to operating expenses of $6.7 million and research and development expenses of $5.3 million for the same period last year. The company reported a net loss for the quarter ended March 31, 2009 of $2.1 million compared to a net loss of $3.9 million for the previous year.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, acute and chronic pain, and xerostomia. The company currently has three clinical stage product candidates: two ionotropic glutamate receptor antagonists and one muscarinic receptor agonist. Further information is available at www.tptxinc.com.

This press rel
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. TorreyPines Therapeutics Reports Third Quarter 2007 Results
7. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
8. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
9. TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2007 Financial Results and Highlights
10. TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast
11. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire/--BlueMarbleEnergyCorp.announcedtodaythatthe...)wererecentlyawarded$2millionbyWashingtonState,sCo.../publicpartnershiptoconstructthestate,sfirstspecia... "Thisinvestmentwillsignificantlyspeedthedevelopme...County,"saidBlueMarbleEnergyCEOKellyOgilvie."Weare...
(Date:11/24/2009)...Newswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHP...day,announcedthatithassubmittedaMAAtotheEuropeanMe...ymereplacementtherapyindevelopment,forthetreatment...icationforvelaglucerasealfathathasbeensubmitted,wi..., Basedonaglobalsupplyshortageofthecurrentlya...
(Date:11/24/2009)...ogram Connects Customers with Partners Validated t...enotek Products , Ottawa,...leading provider of products for biological sample...announced its new global partner program. The prog...k,s partner community and is designed to help part...
(Date:11/23/2009)...hink of it as origami very high-tech origami. , ...eloped a technique for fabricating three-dimension...n films by coupling photolithography and a self-fo... The films, only a few microns thick, offer mechan... pieces of the same material. , "This is a comple...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...Cunnick and Wen Guo Jiang, Metastasis Research Gro... of Wales College of Medicine, Cardiff, UK , ...iogenesis refers to the formation of new lymphatic...mal developing tissues or in tumors. In addition ,...the bloodstream, many malignant , tumors,...
...Tatiana A. Sedova, Bio-Rad Laboratories, , ... , , Manipulating Bits A Gray ... imaging device can be true or altered. , ...pression of more data , retrieved than is...hed , either through software or through ...
...Julio E Celis 1 , Morten stergaard 1 , Pamela Celi... Wolf 2 , 1 Department of Medical Bioc... Research, The University of Aarhus, Aarhus, D... Hospital, Aarhus, Denmark , , B... that includes transitional , cell carcin...
Other Biology Technology:Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 2Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 3Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 4Quantitation of Lymphangiogenesis Using the iCycler iQ Real-Time PCR Detection System and Scorpions Detection System, Rev A 5Not All Bits Are Created Equal 2Not All Bits Are Created Equal 3Not All Bits Are Created Equal 4Not All Bits Are Created Equal 5Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 2Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 3Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 4Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 5Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 6Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 7Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 8Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 9Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 10Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C 11
(Date:11/24/2009)...ass of ring-shaped protein motors has been uncover...nal Laboratory (Berkeley Lab) using a state-of-the...ced Light Source (ALS). These protein motors play ...and are vital to the survival of all biological ce...an papillomavirus, which has been linked to cervic...
(Date:11/24/2009)...search on bacterial communities throughout six lar...poral patterns, suggesting that scientists could u...mate change in the polar regions. The study, publi... Academy of Sciences Early Edition, shows that ba...hronously over time, correlating with seasonal shi...
(Date:11/23/2009)... day matters to forest trees dealing with drought,...eam led by Professor Malcolm Campbell, University ...ch and colleagues in the department of cell and sy...talizing on their previous work to decode the geno...how poplar trees use their 45,000 genes to respond...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Cataract Surgery Doesnt Worsen Macular Degeneration 3A Study 61015 1Cataract Surgery Doesnt Worsen Macular Degeneration 3A Study 61015 2To Feel Better Low Fat Diet May Be Best 61013 1To Feel Better Low Fat Diet May Be Best 61013 2To Feel Better Low Fat Diet May Be Best 61013 3Doctors Spending More Time Now With Patients 61011 1Doctors Spending More Time Now With Patients 61011 2Doctors Spending More Time Now With Patients 61011 3
...PEL HILL, NC In one of the first studies to link ...cy, sociological research published in the August ...fies three genetic predictorsof serious and violen...onsidered together with social influences, such as...ists from the University of North Carolina-Chapel ...
... Yuri Lvov, a professor of chemistry and T. Pipes ...a Tech University, and Anshul Agarwal, a Louisiana... feature their cancer drug reformulation work in t...f the largest and most respected pharmaceutical sc...st Asian pharmacological journal and is turned to ...
...ypical symptom of Parkinson,s disease is tremor in...sor Peter Tass from Forschungszentrum Jlich have s...se the so-called tremor: neuron clusters in the de... supports Tass, research activities aiming at deve...ep brain pacemaker is to bring cells out of the di...
Other Biology News:Sociological research shows combined impact of genetics, social factors on delinquency 2Louisiana Tech researchers feature drug reformulation in prestigious journal 2Louisiana Tech researchers feature drug reformulation in prestigious journal 3'Cross fire' from the brain makes patients tremble 2
Anti-Xanthine Oxidase, Buttermilk Polyclonal Antibody, Unconjugated from CHEMICON
Anti-JNK1 / SAPK Antibody, Unconjugated from Cell Sciences
Acrylamide, Molecular Biology Grade from Research Organics, Inc.
UltraClean Low Melt Agarose from Mo Bio Laboratories, Inc.
Biology Products: